An anticancer peptide fragment of LL-37
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LL-37 (13-37) (human) (trifluoroacetate salt)

Item No. 36949

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
L-isoleucylglycyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-lysyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-arginyl-L-isoleucyl-L-lysyl-L-α-aspartyl-L-phenylalanyl-L-leucyl-L-arginyl-L-asparaginyl-L-leucyl-L-valyl-L-prolyl-L-arginyl-L-threonyl-L-α-glutamyl-L-serine, trifluoroacetate salt
Synonyms
  • CAP-18
  • hCAP-18
  • Cathelicidin
  • FALL-39
  • IG-25
  • LL-13
  • LL-25
Molecular Formula
C137H232N42O36 • XCF3COOH
Formula Weight
3043.6
Purity
≥95%
Formulation (Request formulation change)
A solid
Peptide Sequence
IGKEFKRIVQRIKDFLRNLVPRTES-OH
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥10 mg/mlPBS (pH 7.2): Soluble: ≥10 mg/ml
SMILES
OC(C(F)(F)F)=O.CC[C@H](C)[C@](C(NCC(N[C@@H](CCCCN[H])C(N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@@H](CCCCN[H])C(N[C@@H](CCCNC(N)=N)C(N[C@@](C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@](C(N[C@@H](CCCCN[H])C(N[C@@H](CC(O)=O)C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](C(C)C)C(N1CCC[C@H]1C(N[C@@H](CCCNC(N)=N)C(N[C@]([C@H](O)C)([H])C(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(O)=O)=O)=O)=O)=O)=O)=O)CC(C)C)=O)=O)=O)CC(C)C)=O)CC2=CC=CC=C2)=O)=O)=O)([H])[C@@H](C)CC)=O)=O)=O)=O)([H])[C@@H](C)CC)=O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)=O)([H])N[H]
InChi Code
InChI=1S/C137H232N42O36.C2HF3O2/c1-16-74(12)104(143)127(208)156-68-100(184)157-80(40-25-28-54-138)110(191)162-88(49-52-101(185)186)115(196)169-92(64-78-36-21-19-22-37-78)121(202)160-81(41-26-29-55-139)111(192)158-84(44-32-58-153-135(146)147)118(199)177-108(76(14)18-3)130(211)174-105(72(8)9)128(209)165-87(48-51-98(141)182)114(195)159-85(45-33-59-154-136(148)149)117(198)176-107(75(13)17-2)129(210)164-82(42-27-30-56-140)112(193)172-95(67-103(189)190)124(205)170-93(65-79-38-23-20-24-39-79)122(203)167-90(62-70(4)5)120(201)161-83(43-31-57-152-134(144)145)113(194)171-94(66-99(142)183)123(204)168-91(63-71(6)7)125(206)175-106(73(10)11)132(213)179-61-35-47-97(179)126(207)163-86(46-34-60-155-137(150)151)119(200)178-109(77(15)181)131(212)166-89(50-53-102(187)188)116(197)173-96(69-180)133(214)215;3-2(4,5)1(6)7/h19-24,36-39,70-77,80-97,104-109,180-181H,16-18,25-35,40-69,138-140,143H2,1-15H3,(H2,141,182)(H2,142,183)(H,156,208)(H,157,184)(H,158,192)(H,159,195)(H,160,202)(H,161,201)(H,162,191)(H,163,207)(H,164,210)(H,165,209)(H,166,212)(H,167,203)(H,168,204)(H,169,196)(H,170,205)(H,171,194)(H,172,193)(H,173,197)(H,174,211)(H,175,206)(H,176,198)(H,177,199)(H,178,200)(H,185,186)(H,187,188)(H,189,190)(H,214,215)(H4,144,145,152)(H4,146,147,153)(H4,148,149,154)(H4,150,151,155);(H,6,7)/t74-,75-,76-,77+,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,104-,105-,106-,107-,108-,109-;/m0./s1
InChi Key
BRVMMWFETMTKKJ-GIYKNBIXSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $43

    Add

    5 mg

    $161

    Add

    10 mg

    $280

    Add

    25 mg

    $590

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    LL-37 (13-37) is an anticancer peptide fragment of LL-37 (Item No. 24461).1 It inhibits the ATPase activity of ATP-binding cassette transporter 2, subfamily G (ABCG2) when used at a concentration of 1 µM. LL-37 (13-37) induces cytotoxicity in wild-type SW620 cells and SW620 cells overexpressing P-glycoprotein (P-gp), also known as multidrug resistance protein 1 (MDR1; IC50s = 25.5 and 27.3 µM, respectively), as well as wild-type MCF-7 cells, MCF-7 cells overexpressing ABCG2, and MCF-7 cells overexpressing multidrug resistance-associated protein 1 (MRP1; IC50s = 33.1, 31.8, and 31.1 µM, respectively). It potentiates cytotoxicity induced by mitoxantrone (Item No. 14842) in MCF-7 and HEK293 cells overexpressing ABCG2 when used at concentrations of 5 or 10 µM but not cytotoxicity induced by cisplatin (Item No. 13119) in HEK293 cells overexpressing ABCG2, paclitaxel (Item No. 10461) in SW620 cells overexpressing P-gp, or doxorubicin (Item No. 15007) in MCF-7 cells overexpressing MRP1 at the same concentrations. LL-37 (13-37) (10, 20, or 40 µM) decreases mitoxantrone drug efflux by, and increases mitoxantrone levels in, MCF-7 cells overexpressing ABCG2.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. To, K.K.W., Ren, S.X., Wong, C.C.M., et al. Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells. Peptides 40, 13-21 (2013).